MedTRACK: Tysabri poised for return to market
PharmaLive.com (press release) - Newtown,PA,USA
... According to MedTRACK, there are 14 products currently in phase III trials for multiple sclerosis, and a further 8 ... Biogen Idec's Rituxan (rituximab) is another ...

Genentech and Biogen Idec Submit Supplemental Biologics License ...
PharmaLive.com (press release) - Newtown,PA,USA
... Administration (FDA) for the use of Rituxan® (Rituximab) as first ... needs, including systemic lupus erythematosus, lupus nephritis, multiple sclerosis and ANCA ...